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The specificity of the cytotoxic T  lymphocyte (CTL) 1 response to influenza A 
virus infection in mouse and man has yet to be rigorously defined. The A  virus 
genome codes for two antigenically variable transmembrane glycoproteins, hem- 
agglutinin  (HA),  and  neuraminidase  (NA)  in  addition  to  up  to  eight  more 
conserved non-glycoproteins that are expressed in both abortively and produc- 
tively infected cells (1). 
The  majority of cytotoxic T  cells detectable in  vivo, and early in  polyclonal 
cultures in vitro, cross-react on target cells infected with all  strains of A  viruses 
but  not  B  viruses (2-6).  These  observations  may account  for  the  heterotypic 
protection observed in vivo after infection by serologicaily distinct A viruses (7- 
11) and they raise the question of the identity of the virus products recognized 
by cytotoxic T  cells. Three lines of evidence have implicated the viral hemagglu- 
tinin  as  a  target  molecule  for  cross-reactive  CTL:  experiments  using  Sendai- 
mediated  fusion of influenza  glycoprotein  containing  liposomes to target  cells 
(12), partial blockade of CTL recognition by monoclonal antibodies to the viral 
hemagglutinin  (13), and recently, recognition by some cross-reactive CTL of L 
cells expressing a transfected HA gene (14).  It has also been suggested that  the 
structurally  more conserved nonglycosylated virus proteins are involved in  the 
recognition process (15-21). 
In addition, there is a subpopulation of CTL detectable in the murine response, 
members of which specifically recognize only influenza A viruses closely related 
to  the  strain  used  for  priming  in  vivo  (3-5,  22).  Cytotoxic  cells  with  these 
properties have been selectively stimulated in vitro with purified hemagglutinin 
from A/JAP/305/57 (H2N2) virus (22, 23), but not, as yet, from other A strains. 
Similarly,  subtype  specific  CTL  clones  isolated  from  A/JAP/305/57  primed 
animals display a  recognition  pattern  on partially typed recombinant  A  viruses 
consistent with recognition  of the A/JAP hemagglutinin  on the infected target 
cell  (24),  and  this  has  recently  been  confirmed  using  L  cells  expressing  a 
transfected A/JAP HA gene (14). 
These particular results conform with the idea that cytotoxic T cell recognition, 
Abbreviations used in this  paper:  CTL,  cytotoxic  T lymphocytes;  HA, influenza virus hemagglu- 
tinin; NA, influenza virus  neuraminidase; NP, influenza virus nucleoprotein; PBS,  phosphate-buffered 
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which is assumed to take place at the surface of the infected target cell, should 
be mainly directed at viral glycoproteins that are transported to and inserted in 
the target cell plasma membrane (25). 
Recently, cytotoxic T  cell clones have been  isolated from mice primed  with 
the recombinant A  virus X31  (A/Aichi/68 X A/PR/8/34) (H3N2), or A/PR/8/ 
34  (H1N1),  which  only  lysed  cells  infected  with  specific  A  viruses  (26,  27). 
However, when tested on appropriate genetically typed recombinant viruses it 
was  found  that  the  viral  genes  that  controlled  the  expression  of the  antigens 
apparently recognized by these T  cell clones did not code for glycoproteins. In 
one case recognition mapped  to the A/PR/8/34  gene for P3(PB2) (26) and  in 
our own example (28) to the X31  gene for nucleoprotein (which is derived from 
A/PR/8/34). 
In this paper we extend these results by showing that CTL with specificity for 
the  A/HK/8/68  (H3N2)  nucleoprotein  come  to  predominate  in  polyclonal 
cultures maintained in vitro by repeated stimulation with cells infected with the 
recombinant virus  E61-13-H17  (A/HK/8/68  ×  A/PR/8/34)  (H3N2), and  that 
the influenza A  nucleoprotein gene also plays a  role in  selecting CTL that are 
cross-reactive with influenza A  viruses of different subtypes. 
Materials and Methods 
Mice.  3-6-month old  C57BL/6  female mice  used  as  responding cell donors  were 
obtained from OLAC (OLAC 1976 Ltd; Shaw's Farm, Bicester, Oxon, U.K.). 
In Vivo Priming of Mice.  Mice were anesthetized with ether and primed by intranasal 
infection with 5 hemagglutinin units E61-13-H 17 or X31 virus as infectious allantoic fluid 
diluted in 50 #1 phosphate-buffered saline (PBS), exactly as described previously (22). 
Influenza  Virus  Strains.  The  following  virus  strains  were  used:  Natural  isolates 
H 1N 1 :A/PR/8/1934, A/Eng/1937, A/Bel/1942, A/Weiss/1943, A/Cam/1946, A/FM/ 
1/1947, A/USSR/90/1977; H2N2:A/JAP/305/57; H3N2:A/Aichi/1/1968, A/Bangkok/ 
1/1979; B virus: B/Hong Kong/8] 1973; Recombinant A viruses: E61-13-H 17, X31, X47, 
X61, X45, X57. The parental viruses used to make each of these recombinants and their 
resulting genotypes are given in Table I, and described in detail in references 29 and 30 
(E61-13-H 17 is referred to as recombinant number 33 in reference 30). 
Virus  was grown  in  the allantoic sacks  of 11-d old embryonated chicken eggs,  and 
stored as infectious allantoic fluid at -70 ° C. 
Continuous  Cytotoxic T Cell Cultures In Vitro.  The methods used to maintain influenza 
A specific cytotoxic T  cell cultures in continuous growth in vitro have been described in 
detail elsewhere (31 ). 
4 wk after priming by intranasal infection in vivo, two donor C57BL/6 spleens were 
pooled and a cell suspension made.  1.2 x  I07 responding cells were mixed with 5 x  105 
infected  stimulator  cells  in  15  ml  RPMI/10  (Gibco  RPMI  1640,  10%  FCS,  2  mm 
glutamine, 100 IU/ml penicillin, 100 tag/ml streptomycin, 5 x  10  -5 M 2-mercaptoethanol) 
in 50-ml Nunc flasks (Gibco Ltd; Paisley, Scotland, U.K.). 
Stimulator cells were syngeneic normal spleen cells irradiated with 2,000R, and infected 
in the absence of foetal calf serum with 0.5 ml infectious allantoic fluid/3 ml RPMI 1640/ 
108  spleen cells.  Stimulator cells were washed  three  times in  PBS before addition  to 
cultures. 
After l  wk incubation at 37°C the responding cells were harvested and restimulated 
with 5 ×  106 stimulator cells. After another week the responding cells were harvested and 
2 x  l05 restimulated with 5 x  105 stimulator cells in  12 ml RPMI/10 adjusted to 20% 
vol/vol with a crude preparation of rat T cell growth factors (R/S described below). Such 
cultures were maintained in exponential growth by repeated identical stimulations every 554  CTL  RECOGNITION  OF  INFLUENZA  A  NUCLEOPROTEIN 
7 d. If the culture became obviously acidic before the seventh day, half the medium was 
replaced by fresh R P M I/10/10 % R/S. 
A lectin-free T  cell growth factor preparation was made using a modification of the 
method described by Speiss and Rosenberg (32).  A spleen cell suspension was prepared 
from PVG or Lewis rats (without lysing red cells) and adjusted to 2 ×  107 lymphocytes/ 
ml in RPMI/10. Con A (Sigma Type III, Sigma London Chemical Co, Ltd; Poole, Dorset, 
U.K.) was added to a final concentration of 20/~g/ml and the mixture incubated at 37 °C 
for 2  h.  The cells were then centrifuged at 400 g for 10 rain and washed twice in the 
same  volume of PBS,  before resuspension  at  5  X  10  6  cells  per  ml  in  RPMI/10  and 
incubation at 37 °C for 48 h. The supernatant (R/S) was then harvested, millipore filtered, 
and stored at -40°C in aliquots. 
Cytotoxicity Assay.  A  standard  6-b  chromium  51  release assay  was  used  as  described 
previously (31).  Briefly, EL4 (H-2b) target cells were labeled and infected for 90 min in 
suspension at 37°C with  150 #Ci Cr  51 (Amersham International Ltd; Amersham, Bucks, 
U.K.) in 0.5 ml serum-free RPMI  1640 and 50-400 #1 of infectious allantoic fluid. After 
washing four times with 10 ml PBS, 2 X 104 target cells/0.1 ml RPMI/10 were dispensed 
into 96-well flat-bottomed Costar microtiter plates (L. H. Engineering Co, Ltd; Bell's Hill, 
Stoke Poges, Bucks, U.K.), and effector CTL were then added in 0.1  ml RPMI/10. The 
plates were centrifuged for 1 min at 400 g then incubated for 6 h, and recentrifuged for 
5 min at 400 g before harvesting 0.1  ml of supernatant for radioactivity determination. 
Percent specific chromium release was calculated as follows: 
(Release by CTL -  Medium release) X  100/(2.5% Triton release -  Medium release). 
All points were measured in duplicate against quadruplicate medium controls. Sponta- 
neous chromium  51  release in  the absence of CTL ranged between 9% and  34% in all 
experiments. 
Results 
Selection of an A Virus Subtype-Specific Population of CTL by Repeated Stimulation 
with E61-13-HI7  Virus.  In a  previous communication we described the effect 
of repeated  stimulation  in  vitro  with  X31  virus-infected  stimulator  cells  on 
spleen  cells  from  X31-primed  mice,  in  selecting  CTL  with  specificity  for  a 
subgroup of A  viruses that could then be cloned at high frequency (27). Target 
cell recognition by one of these clones, when  tested on a  discriminating set of 
recombinant A  viruses mapped to the A/PR/8/34  gene for nucleoprotein (28). 
In order to examine this effect in more detail the E61-13-H17 virus was chosen 
in the present experiments to prime C57BL/6 mice. This virus differs from X31 
only in  its gene for NP which originates from its  1968  H3N2  parent (Table I 
and references 29,  30). 
4 wk after priming, in vitro cultures were set up as described in Materials and 
Methods.  Responding cells from two E61-13-H 17-primed spleens were pooled 
and  divided  into  two  parts.  One  part  was  maintained  in  vitro  by  repeated 
stimulation  with  E61-13-H17-infected  feeder  cells,  and  the  second  part  in 
identical conditions but stimulated by X31-infected feeder cells. The two parallel 
cultures  were tested  on  week  2  (at  which  point  a  source of lectin  free T  cell 
growth factors was added) and week 7 of in vitro growth. 
Fig.  1  shows  the  virus  specificity  of the  two  cultures  at  week  2  after  two 
stimulations with antigen.  In the left-hand panel the E61-13-H 17-restimulated 
culture is shown; both the E61-! 3-H 17- and X31-infected targets were lysed, the 
former  more  efficiently  than  the  latter.  In  the  right-hand  panel  the  X31- 
stimulated half of the culture is shown; these effector cells clearly lysed the X31- TOWNSEND  AND  SKEHEL  555 
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FIGURE  ].  The specificity  of the two cultures  derived from C5?BL/6 cells primed with E6]- 
13-H 17 virus in vivo after two stimulations at weekly intervals in vitro, A: with E6 l-I 3-H 17- 
infected feeder  cells;  B:  with X31  infected  feeder  cells.  0,  E61-13-H17-infected; &,  X31- 
infected; ©, uninfected EL4 target cells. 
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FIGURE 2.  The specificity of the same two cultures after seven identical weekly stimulations 
in vitro, A: with E61-13-H 17-infected feeder cells, B: with X31 infected feeder cells. 0, E61- 
13-H 17-infected; &, X31-infected; l  B/Hong Kong-infected EL4 target cells. 
infected target as efficiently as the E61-13-H 17 target. Thus, already at week 2 
in vitro the E61-13-H 17-restimulated  culture was showing a  detectable differ- 
ence  in  the  efficiency  with  which  it  could  lyse  target  cells  infected  with  two 
viruses that differ only in their NP genes. 
This tendency becomes more marked with time. Fig. 2 depicts a repeat of the 
same test at week 7 in vitro after seven identical stimulations with virus-infected 
feeder cells. At this stage  the E61-13-H17-restimulated  portion of responding 
cells gives very weak lysis of X31-infected  targets in comparison with the X31- 556  CTL  RECOGNITION OF  INFLUENZA  A  NUCLEOPROTE|N 
restimulated portion  that  lysed target cells infected with either X31  or E61-13- 
H 17. The A  virus specificity of both cultures is confirmed by the absence of lysis 
of B/Hong Kong/8/73  infected target cells. 
Mapping  the  Recognition  of E61-13-H17  Specific  CTL  to  the  1968  Nucleopro- 
tein.  In  order  to  confirm  the  specificity of the  E61-13-Hl7-restimulated  re- 
sponder  cells,  a  set of independent  genetically  typed  recombinant  viruses and 
natural  isolates  were  used  to  infect  target  cells.  Each  of the  six  recombinant 
viruses resulted  from a  cross between an  H3N2  virus and  A/PR/8/34,  and all 
have been described  in detail  in  the  literature  (29,  30).  The genotypes of each 
virus are shown in Table I. 
Fig.  3  describes  the  recognition  by the  two  CTL  populations  after  9  wk  of 
growth in  vitro, of target cells infected with these viruses. The first two panels 
confirm the E61-13-H 17-restimulated culture  recognized E61-13-H 17-infected 
but not X31-infected cells.  These two viruses differ only in their genes for NP. 
The  H3N2 glycoprotein genes originated in these two viruses from A/Aichi/2/ 
68  and  A/HK/8/68,  which  are  probably identical.  This  result,  in  conjunction 
with  the  results  with  wild  type  viruses  described  below,  show  that  the  H3N2 
glycoproteins do  not  play a  role in  recognition  by these  selected effector cells. 
Minor differences in the H3N2 glycoproteins in the remaining four recombinant 
viruses (originating from H3N2 viruses isolated in different years) can therefore 
be ignored. These four recombinant viruses consist of two pairs (X61, X47, and 
X51, X45) each of which also differ only in the origin of their genes for NP (29). 
The remaining six panels of Fig. 3 show that the specificity of the E61-13-H 17- 
restimulated  CTL  is  determined  by the  gene  for  NP  in  viruses  isolated  after 
1968, and are summarized in Table I. 
In  contrast,  the  half  of  the  E61-13-H17-primed  responder  cells  that  was 
TABLE  I 
Polyclonal CTL with Specificity  for the Post-1968 Influenza A Nucleoprotein 
Parental H3N2  Test virus  PB1  PA  PB2  HA  NA  NP  M  virus 
Activ- 
ity of 
NS  CTL 
lines 
A  B 
E6113H17  A/HK/8/68  •  •  •  +  + 
X31  A/Aichi/2/68  •  •  -  + 
X47  A/Vic/3/75  •  •  •  •  +  + 
X61  A/Texas/I/77  •  •  •  -  + 
X45  A/Scot/840/74  •  •  •  •  •  +  + 
X57  A/Vic/112/76  •  •  •  •  -  + 
A/Aichi/68  •  •  •  •  •  •  •  •  +  + 
A/PR/8/34  -  + 
Summary of the tests done to map recognition by the two cultures described in Figs. 2 and 3 to the 
influenza A gene for nucleoprotein.  All the recombinant  viruses tested were derived from mixed 
infections with A/PR]8[34 (H1NI) and post-1968 H3N2 viruses (29, 30). In the table the H3N2 
parental virus is listed for each recombinant virus and the genotype of each is shown by representing 
genes derived from the H3N2 parent by •  and those derived from A]PR]8134 as blanks. CTL line 
A, the polyclonal culture shown in Fig. 2A; CTL line B, the culture shown in Fig. 2B. PBI, PA, PB2, 
genes coding for polymerase proteins; HA, hemagglutinin; NA, neuraminidase; NP, nucleoprotein; 
M, matrix protein; NS, no•structural proteins. TOWNSEND  AND  SKEHEL  557 
~1-13-H17  ×31  ×47  ×61 
80 
% 
~_  X45  X57  AIAichi/68  A/PR/8/'M 
80 
K:T  5  2.5  l.?  0.6  5  2.5  1.2  0.6  5  Z5  1.2  0.6  5  Z5  1.2  0.6 
FIGURE 3.  Recognition by the same two cultures of EL4 target cells infected with a discrim- 
inating set of recombinant A  viruses. O,  E61-13-H 17-primed and restimulated effectors; O, 
E61-13-H 17 primed, X 31-restimulated effectors. 
maintained in  parallel by restimulation with X31-infected feeder cells in vitro 
remained cross-reactive on all the A virus-infected target cells tested, including 
the two widely separated natural  isolates A/PR/8/1934  (HI N1) and A/Aichi/ 
1968 (H3N2). 
Recognition of Natural Influenza A Virus Isolates by the E61-13-H17-Spec~c CTL 
Population.  The previously mentioned CTL clone with specificity that mapped 
to  the  A/PR/8/34  gene for  NP,  when  tested  on  a  range  of natural  A  virus 
isolates,  revealed a  clear-cut division between those that could and those that 
could not sensitize target cells for lysis. Viruses isolated between 1934 (A/PR/8/ 
34) and  1943  (A/Weiss/43) were recognized, those isolated in  1946  and later 
were not (27). The timing of this change coincides with an antigenic change in 
the nucleoprotein molecule defined using rabbit antisera to purified NP (33, 34) 
and certain monoclonal antibodies (35). 
The activity of the E61-13-H 17-restimulated effector cells on targets infected 
with a range of natural viruses is shown in Fig. 4 and summarized in Table II. 
In this case lysis of target cells infected with the  1934,  1937,  1942,  and  1943 
viruses was weak or absent (compared to background lysis of uninfected or B/ 
Hong  Kong-infected cells),  whereas all  the  target  cells  infected with  viruses 
isolated  from  1946  onwards,  including representatives of H1N1,  H2N2,  and 
H3N2  subtypes,  were lysed efficiently by the E61-13-H17-restimulated  CTL 
population. This result confirms that recognition of infected target cells by these 
effector cells in independent of the type of glycoproteins expressed, and gives 
the exact reciprocal pattern of our previously described CTL clone with specific- 
ity for the 1934 nucleoprotein (27). 558  CTL  RECOGNITION  OF  INFLUENZA  A  NUCLEOPROTEIN 
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FIGURE 4.  (A)  Recognition  by  the  E61-13-Hl7-restimulated  culture  of  EL4  target  cells 
infected with natural influenza A viruses isolated between 1934 (34) and  1943 (43),  A; 1946 
(46) and  1979  (79),  A; B/Hong Kong infected, II; and uninfected, I-7. (B) Recognition by a 
cross-reactive control  culture  of the  same  panel  of target  cells.  The  control  culture  was 
provided in this case by spleen cells primed in vivo with E61-13-H 17 virus and restimulated 
twice at weekly intervals with X31  virus in vitro. 
TABLE  II 
Recognition by the Nucleoprotein-specific Culture of Natural 
Influenza  Viruses Isolated between 1934-1979 
Test virus  Subtype 
Activity of CTL lines 
E61-13-H17  Con- 
Restimulated  trol 
A/PR/8/1934  H 1  N 1  -  + 
A/Eng/1937  H 1  N 1  -  + 
A/Bel/1942  H 1N 1  -  + 
A/Weiss/1943  H 1  N 1  -  + 
A/Cam/1946  H 1  N 1  +  + 
A/FM/1/1947  H1N1  +  + 
A/USSR/90/1977  H 1N 1  +  + 
A/Jap/305/1957  H2N2  +  + 
A/Aichi/1/1968  H3N2  +  + 
A/Bangkok/I/1979  H3N2  +  + 
Summary  of  the  recognition  of  target  EL4  cells  infected  by  natural 
influenza A viruses isolated between 1934 and 1979, by the E61-13-H 17- 
restimulated culture and  a  cross-reactive control.  The control was  pro- 
vided in this experiment by C57BL/6 spleen cells primed with E61-13- 
H17  in  vivo and  restimulated  twice in  vitro with  X31  as described  in 
Materials and Methods. 
Cross-reactive  control  CTL  lysed all the A  virus-infected  target  cells, showing 
that  the  lack  of  lysis  by  the  E61-13-H17-specific  CTL  of  1934-1943  virus- 
infected  targets  was  not  due  to  failure  of these  viruses  to  infect.  The  relatively 
inefficient  infection  of target  cells by  A/Weiss/43  is a  consistent  feature  in  our 
hands,  and  in  four  independent  experiments  the  same  results  were  obtained. TOWNSEND  AND  SKEHEL  559 
The cross-reactive control culture was provided by C57BL/6 spleen cells primed 
in vivo with E61-13-H 17 virus, and restimulated in vitro twice with X31 virus as 
described in Materials and Methods. 
Discussion 
In this paper we have extended our previous results to show that the genes for 
NP of both  1968 (H3N2) and  1934 (H1N1) influenza A  viruses appear able to 
determine the recognition of infected target cells by cytotoxic T  cells. 
The antigenic determinant we have defined here with the E61-13-H 17-restim- 
ulated culture appears to be immunodominant  in C57BL/6 cultures in vitro. A 
polyclonal effector cell population  that begins in vitro by showing lysis of both 
X31- and  E61-13-H17-infected  targets (Fig.  1), after 7 wk of stimulation  with 
E61-13-H 17-infected feeder cells loses the ability to recognize X31 while retain- 
ing efficient recognition of E61-13-H 17-infected cells. The recognition of other 
recombinant  A  virus-infected  targets  (Fig.  3 and  Table  I) segregates with  the 
gene for NP of viruses isolated after 1968. Furthermore,  the ability to recognize 
target cells infected with  natural  A  viruses isolated in  the years between  1934 
and  1979 (Fig. 4 and Table II) correlates with a change in the antigenic nature 
of  the  NP  molecule  defined  with  a  rabbit  antiserum  (33,  34)  and  certain 
monocional antibodies (35). 
In contrast,  when the same spleen cells primed in vivo with E61-13-H17 are 
maintained in vitro for the same length of time by stimulation with X31-infected 
feeder cells, the selected effector cells remain  cross-reactive on targets infected 
with A/PR/8/34 (H1N1) and A/Aichi/68 (H3N2) (Fig. 3). As X31 differs from 
E61-13-H17 only in its gene for NP (29,  30), this gene must play a  role in the 
selection of both A virus cross-reactive and subgroup-specific cytotoxic T  cells. 
Influenza A nucleoprotein is detectable early in both abortive and productive 
infections, and becomes the predominant  viral protein in the nuclei of infected 
cells (1,  36,  37).  The primary  structure  of the  NP molecule does not reveal a 
hydrophobic stretch of sequence analogous to that found in characterized  inte- 
gral  membrane  proteins  (38,  39),  although  this  does not  rule  out  membrane 
association. There are reports that  NP can be detected on the external surface 
of abortively infected cells (15,  16) and  in  the  latter  study a  semiquantitative 
RIA method was used with several monoclonal antibodies to show that NP could 
be detected at a  maximum of up to  10% of the amount of HA at the surface of 
influenza A virus-infected P815 cells. The significance of these observations to 
the recognition of infected cells by CTL is not known. 
The possible roles of the influenza nucleoprotein in T  cell recognition can be 
considered to involve either direct recognition of the nucleoprotein molecule by 
the cytotoxic T  cell or indirect recognition of a  determinant  at the cell surface 
induced or controlled by the nucleoprotein. Direct recognition could be mediated 
either by the  low level of cell surface expression previously described (16),  or 
conceivably by a mechanism analogous to antigen processing involving fragmen- 
tation  of the  nucleoprotein  and  "presentation"  by  the  infected  cell.  Indirect 
recognition  could  be  mediated  possibly  by  an  effect  of  NP  on  one  of  the 
glycoproteins of the virus or by conformational changes induced in H-2 molecules 
by NP interacting  with their  cytoplasmic domains.  However, the latter mecha- 560  CTL  RECOGNITION  OF  INFLUENZA  A  NUCLEOPROTEIN 
nism appears  less  likely in  the light of results by Murre et al.  (40),  who have 
shown that an L  d molecule truncated by the loss of its cytoplasmic domain still 
functions efficiently as a restriction element for influenza A-specific CTL. 
Considerations similar to these have been presented for the possible mecha- 
nisms involved in  recognition by CTL of the SV40  large T  antigen (41-43). 
Furthermore, in that system Tevethia et al. (42) have recently demonstrated that 
L cells transfected with a plasmid containing the large T  gene became recogniz- 
able as targets for SV40-specific CTL. Recognition by subpopulations of T  cells 
could be mapped using target cells expressing N or C terminal fragments of the 
protein  (43).  Similar  experiments  using  cDNA  copies  of influenza  genes  to 
transfect target cells will be helpful in explaining the role of the NP in recognition 
by the cytotoxic T  cells described in this report, and are in progress. 
Sequence comparisons between the A/PR/8/34  (HI N 1) (38) and A/NT/60/ 
68 (H3N2) (39) nucleoprotein genes reveal only 30 amino acid changes out of 
498  (94%  conservation).  Since  the  CTL  selected  in  the  E61-13-H17-specific 
culture can clearly discriminate between A/Weiss/43  and A/Cam/46  (Fig.  4), 
and the difference in sequence between the nucleoproteins of these two viruses 
is likely to be small, it appears that these cytotoxic T  cells are sensitive to such 
small changes in nucleoprotein structure. At the same time, the fact that the NP 
molecule is 94% conserved in influenza A viruses also makes it a logical candidate 
as a target for CTL cross-reactive on all influenza A virus-infected cells. 
By selecting immunodominant clones of cytotoxic T  cells in  the  C57BL/6 
mouse strain,  the method used here of repeated stimulation with a  genetically 
typed recombinant virus in vitro may oversimplify the range of CTL specificities 
produced. A  recent analysis by Vitielio and Sherman (44) of cytotoxic T  cell 
clones isolated by limiting dilution after one stimulation in vitro, implied a  far 
greater diversity in  the virus specificities defined in  a  C57BL/6J  response.  A 
similar experiment by  Kees and  Krammer (45),  by  using appropriately typed 
recombinant viruses to infect target cells, has shown that as many as 90% of such 
clones stimulated in limiting dilution cultures from C57BL/6 mice could differ- 
entiate between A viruses, and recognized determinants that were controlled by 
viral genes that segregated independently of the two glycoproteins. The propor- 
tion of these that map to the virus nucleoprotein awaits to be seen. 
Summary 
Using genetically typed recombinant influenza A  viruses that differ only in 
their genes for nucleoprotein, we have demonstrated that repeated stimulation 
in vitro of C57BL/6 spleen cells primed in vivo with E61-13-H 17 (H3N2) virus 
results in the selection of a population of cytotoxic T  iymphocytes (CTL) whose 
recognition of infected target cells maps to the gene for nucleoprotein of the 
1968  virus.  Influenza A  viruses isolated between  1934 and  1979  fall into two 
groups defined by their ability to sensitize target cells for lysis by these CTL: 
1934-1943  form  one  group  (A/PR/8/34  related)  and  1946-1979  form  the 
second group (A/HK/8/68 related). These findings complement and extend our 
previous results with an isolated CTL clone with specificity for the 1934 nucleo- 
protein (27, 28). 
It is also shown that the same spleen cells derived from mice primed with E61- TOWNSEND  AND  SKEHEL  561 
13-H 17 virus in vivo, but maintained in identical conditions by stimulation with 
X31  virus (which differs from the former only in the origin of its gene for NP) 
in vitro, results in the selection of CTL that cross-react on target cells infected 
with A/PR/8/1934  (H 1N 1) or A/Aichi/1968 (H3N2). 
These results show that the influenza A  virus gene for NP can play a  role in 
selecting  CTL  with  different specificities and  implicate  the  NP  molecule as a 
candidate for a  target structure recognized by both subtype-directed and cross- 
reactive influenza A-specific cytotoxic T  cells. 
The authors are grateful to Dr. P. Palese for donating recombinant viruses and reading 
the manuscript, and to the Medical Research Council of Great Britain for support. 
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